MPG.eBooks - Description: Third-line pharmacotherapy for type 2 diabetes

Read Now

The objective of this review was to update the systematic review and network meta-analysis of third-line therapies for type 2 diabetes

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2013, July 2013
Series:	CADTH optimal use report
Subjects:	Metformin / Therapeutic Use Canada Cost-benefit Analysis Hypoglycemic Agents / Therapeutic Use Diabetes Mellitus, Type 2 / Drug Therapy Diabetes Mellitus, Type 2 / Economics Treatment Outcome Sulfonylurea Compounds / Therapeutic Use
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK361972
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this review was to update the systematic review and network meta-analysis of third-line therapies for type 2 diabetes
Physical Description:	1 PDF file (vii, 76 pages) illustrations